Stay updated on HY209 Gel Phase I Clinical Trial
Sign up to get notified when there's something new on the HY209 Gel Phase I Clinical Trial page.

Latest updates to the HY209 Gel Phase I Clinical Trial page
- CheckyesterdayChange DetectedPage revision updated from v3.5.0 to v3.5.2.SummaryDifference0.1%

- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check30 days agoChange DetectedRevision updated to v3.5.0 and the previous v3.4.3 revision was removed.SummaryDifference0.1%

- Check37 days agoChange DetectedRevision: v3.4.3 has been applied, replacing v3.4.2.SummaryDifference0.1%

- Check66 days agoChange DetectedThe footer now displays Revision: v3.4.2, replacing the previous v3.4.1. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check73 days agoChange DetectedOnly a site revision update from v3.4.0 to v3.4.1 is visible, with no changes to study details, eligibility criteria, or results. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check80 days agoChange DetectedAdded a glossary toggle; updated several UI labels for capitalization (e.g., 'Last Update Submitted that Met QC Criteria' and 'No FEAR Act Data'); and updated the footer revision from v3.3.4 to v3.4.0. These are formatting and metadata updates that do not modify study details. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

Stay in the know with updates to HY209 Gel Phase I Clinical Trial
Enter your email address, and we'll notify you when there's something new on the HY209 Gel Phase I Clinical Trial page.